Bavarian Nordic
197.55
DKK
+1.46 %
BAVA
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
+1.46%
+4.33%
+2.41%
-9.01%
+6.78%
+24.09%
-9.59%
+28.79%
+38.5%
Bavarian Nordic is a biochemistry company. Today, the company specializes in the development, manufacture, and distribution of vaccines against infectious diseases in connection with cancer treatment. In addition, vaccines against other serious diseases such as Ebola and cervical cancer are also being developed. The largest operations are located in Europe and in the U.S. Bavarian Nordic was founded in 1994 and is headquartered in Kvistgaard, Denmark.
Read moreMarket cap
15.58B DKK
Turnover
13.82M DKK
Revenue
7.06B
EBIT %
21.28 %
P/E
10.29
Dividend yield-%
-
Financial calendar
5.3
2025
Annual report '24
9.4
2025
General meeting '25
9.5
2025
Interim report Q1'25
ShowingAll content types
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
Bavarian Nordic lancerer planlagt aktietilbagekøbsprogram for DKK 150 mio.
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Bavarian Nordic Launches Planned Share Buy-Back Program of DKK 150 Million
Aktier i Vælten - Et tilbageblik på bevægelserne i OMXC25 i 2024, og nogle forudsigelser for 2025
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India
Bavarian Nordic indgår licens- og produktionsaftale omkring mpox-vaccine med Serum Institute of India
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Bavarian Nordic iværksætter nyt incitamentsprogram for koncernledelsen og udvalgte medarbejdere
New Incentive Program Established for Members of Executive Management and Selected Employees in Bavarian Nordic
Bavarian Nordic vil foretage aktietilbagekøb for DKK 150 mio.
Bavarian Nordic to Launch DKK 150 Million Share Buy-back Program
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
Indberetning af ledende medarbejdere og disses nærtståendes transaktioner med Bavarian Nordic aktier og tilknyttede værdipapirer
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner